跳至主要内容
临床试验/NCT00685321
NCT00685321Unknown不适用

A Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia

Shalvata Mental Health Center2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2008年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
45
试验地点
2
主要终点
SANS

研究概览

简要总结

Objectives:The purpose of the study is to explore the efficacy and safety of H1-Coil deep brain rTMS in subjects with negative symptoms and cognitive deficits of schizophrenia (deficit syndrome), currently treated with atypical antipsychotics.

Patient Population: The intention is to treat 45 patients diagnosed with schizophrenia, who are currently suffering mainly from negative symptoms and cognitive deficits (deficit syndrome). The patients will be of all racial, ethnic and gender categories, ranging from 18 to 65 years of age, and have PANSS negative≥21 and PANSS positive<24. Patients will be recruited from both academic and private research centers.

Structure: The study is a randomized, prospective, 8 weeks, double blind study. Blinding: The treatment administrator and the study personnel and patients will be masked to the treatment being administrated.

Concurrent Control: The study group will receive active rTMS treatment and the control group will receive an inactive, sham treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between the ages of 18-65 (male and female), Diagnosed in the past as suffering from schizophrenia. The diagnosis will be reaffirmed according to ICD criteria.
  • Right hand dominant.
  • Scores in PANSS negative questionnaire above
  • Gave informed consent for participation in the study.
  • Negative answers on safety screening questionnaire for transcranial magnetic stimulation
  • stable on the same antipsychotic medication for at least two months prior to entering the study.
  • Negative answers to all questions in the TMS safety questionnaire (attached ).

排除标准

  • Diagnosed as suffering from another axis 1 disorder .
  • Scores in PANSS positive questionnaire above
  • History of epilepsy, seizure, or hot spasm.
  • History of epilepsy within first-degree relatives.
  • History of head injuries.
  • History of metal in the head (outside the mouth space).
  • History of surgery including metal implant or history of metal particles in the eye, pacemaker, or any other medical pump.
  • History of migraines.
  • History of hearing loss (not due to aging) or cochlear implants.
  • History of drug or alcohol abuse during the last year.
  • Women - Pregnancy or not using a reliable method of birth control.
  • Inability to achieve satisfying level of communication with the subject.
  • suicide attempt in the year prior to treatment or suicide risk according to a suicide questionnaire
  • Custodians.
  • Participation in another medical study during the experiment.

结局指标

主要结局

SANS

时间窗: 1.5 year

次要结局

  • SOFAS(1.5 Year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Tolerability, Safety and Efficacy of the H1-coil... | 临床试验